✦ LIBER ✦

Risk-based Quality by Design (QbD): A Taguchi Perspective on the Assessment of Product Quality, and the Quantitative Linkage of Drug Product Parameters and Clinical Performance

✍ Scribed by Robert P. Cogdill; James K. Drennen

Book ID: 107635816
Publisher: Springer US
Year: 2008
Tongue: English
Weight: 296 KB
Volume: 3
Category: Article
ISSN: 1872-5120
DOI: 10.1007/s12247-008-9025-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Examining the impact of excipient materi

Examining the impact of excipient material property variation on drug product quality attributes: A quality-by-design study for a roller compacted, immediate release tablet

✍ JOSEPH Kushner IV; Beth A. Langdon; Jon I. Hiller; Glenn T. Carlson 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 983 KB

A quality-by-design study examining the impact of variability in excipient material properties on the quality attributes of an immediate release tablet was performed. A literature review and risk analysis identified particle size of microcrystalline cellulose (MCC), spray-dried lactose (SDL), and ma

A new definition of pharmaceutical quali

A new definition of pharmaceutical quality: Assembly of a risk simulation platform to investigate the impact of manufacturing/product variability on clinical performance

✍ Steven M. Short; Robert P. Cogdill; Frank D'Amico; James K. Drennen III; Carl A. 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 477 KB 👁 1 views

The absence of a unanimous, industry-specific definition of quality is, to a certain degree, impeding the progress of ongoing efforts to "modernize" the pharmaceutical industry. This work was predicated on requests by Dr. Woodcock (FDA) to re-define pharmaceutical quality in terms of risk by linking